Skip to content

Use of multiple frequency Bioimpedance in determining the status of hydration and its impact on blood pressure control, arterial stiffness, cardiac changes, and inflammation status in peritoneal dialysis

Use of Multifrequency Bioimpedance in determining the status of hydration and its impact on intermediate outcomes in peritoneal dialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-10k8j3bx
Enrollment
Unknown
Registered
2022-03-03
Start date
2019-10-14
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other dialysis

Interventions

Randomized controlled intervention study, carried out in adult patients with chronic kidney disease undergoing peritoneal dialysis treatment at the Dialysis Unit of Hospital das Clínicas, Botucatu Sch

Sponsors

Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Júlio de Mesquita Filho"
Lead Sponsor
Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Júlio de Mesquita Filho"
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients over the age of 18, on a peritoneal dialysis program for a period of three months or more, who agreed to participate by signing the informed consent form.

Exclusion criteria

Exclusion criteria: Cardiac pacemakers, metallic implants, amputees, malignant neoplasms, liver cirrhosis, active infectious diseases, unstable heart diseases (acute coronary syndrome, unstable arrhythmias), and severe left ventricular systolic dysfunction (ejection fraction below 30%). The interruption of follow-up will be indicated when there are adverse treatment effects that cannot be controlled by the routine dialysis procedure, such as refractory hypervolemia and arterial hypotension; acute infections, in addition to acute cardiovascular and cerebrovascular events and the express manifestation of the patient by the discontinuation of the intervention protocol.

Design outcomes

Primary

MeasureTime frame
Difference of 5% in the measure of relative hyperhydration (OH/AEC%) between the groups at the end of the intervention, evaluated by bioimpedance spectroscopy, with an estimated standard deviation of 4.8%

Secondary

MeasureTime frame
Difference of 12 mmHg in mean systolic blood pressure between groups at the end of the intervention, measured by the 24-hour ambulatory blood pressure monitoring device, with an estimated standard deviation of 17 mmHg

Countries

Brazil

Contacts

Public ContactPasqual Barretti

Faculdade de Medicina de Botucatu - Universidade Estadual Paulista "Júlio de Mesquita Filho"

pasqual.barretti@unesp.br+55(014)955865119

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 11, 2026